TESTOSTERONE UNDECYLATE
brca1 Mutation Carrier
City of Hope Medical CenterSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the brca1 Mutation Carrier cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olaparib VA Office of Research and Development | Phase 3 | BB |
Carboplatin VA Office of Research and Development | Phase 2 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II University Health Network, Toronto | Phase 2/3 | BB |
Veliparib AbbVie | Phase 2 | BB |
Letrozole UNICANCER | Phase 3 | BB |
View all 26 →
Same molecule, other indications
TESTOSTERONE UNDECYLATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →